HU905134D0 - Molecular antibodies for the indication of tolerance - Google Patents
Molecular antibodies for the indication of toleranceInfo
- Publication number
- HU905134D0 HU905134D0 HU905134A HU513490A HU905134D0 HU 905134 D0 HU905134 D0 HU 905134D0 HU 905134 A HU905134 A HU 905134A HU 513490 A HU513490 A HU 513490A HU 905134 D0 HU905134 D0 HU 905134D0
- Authority
- HU
- Hungary
- Prior art keywords
- tolerance
- depleting
- indication
- monoclonal antibody
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898912497A GB8912497D0 (en) | 1989-05-31 | 1989-05-31 | Monoclonal antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
HU905134D0 true HU905134D0 (en) | 1992-02-28 |
HUT61341A HUT61341A (en) | 1992-12-28 |
Family
ID=10657649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU905134A HUT61341A (en) | 1989-05-31 | 1990-05-31 | Monoclonal antibodies for inducing tolerance |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0474691B1 (hu) |
JP (1) | JP2763197B2 (hu) |
KR (1) | KR0183029B1 (hu) |
AT (1) | ATE145246T1 (hu) |
AU (1) | AU657255B2 (hu) |
CA (1) | CA2055615C (hu) |
DD (1) | DD296843A5 (hu) |
DE (1) | DE69029134T2 (hu) |
DK (1) | DK0474691T3 (hu) |
ES (1) | ES2096588T3 (hu) |
GB (1) | GB8912497D0 (hu) |
HU (1) | HUT61341A (hu) |
IE (1) | IE80735B1 (hu) |
IL (1) | IL94566A0 (hu) |
MY (1) | MY135673A (hu) |
NZ (1) | NZ233889A (hu) |
PT (1) | PT94214B (hu) |
WO (1) | WO1990015152A1 (hu) |
ZA (1) | ZA904174B (hu) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9100741D0 (en) * | 1991-01-14 | 1991-02-27 | Univ London | Treatment of disease |
US6136310A (en) | 1991-07-25 | 2000-10-24 | Idec Pharmaceuticals Corporation | Recombinant anti-CD4 antibodies for human therapy |
DE69315847T2 (de) * | 1992-08-21 | 1998-06-25 | Genentech Inc | Verfahren zur behandlung einer durch lfa-1 vermittelten störung |
US6270766B1 (en) | 1992-10-08 | 2001-08-07 | The Kennedy Institute Of Rheumatology | Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
PT840618E (pt) * | 1995-05-18 | 2003-08-29 | Ortho Mcneil Pharm Inc | Inducao de tolerancia imunologica atraves de anticorpos anti-cd4 nao-depletores |
MXPA02001911A (es) | 1999-08-24 | 2003-07-21 | Medarex Inc | Anticuerpos ctla-4 humanos y sus usos. |
US7011952B2 (en) | 2000-02-22 | 2006-03-14 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
EP1287364B1 (en) | 2000-04-29 | 2008-10-22 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
JP4448906B2 (ja) * | 2001-06-14 | 2010-04-14 | イシス イノベーション リミテッド | Cd4特異的抗体trx1およびその使用 |
US7541443B2 (en) * | 2001-06-14 | 2009-06-02 | Tolerrx, Inc. | Anti-CD4 antibodies |
EP1460088A1 (en) | 2003-03-21 | 2004-09-22 | Biotest AG | Humanized anti-CD4 antibody with immunosuppressive properties |
GB0314461D0 (en) * | 2003-06-20 | 2003-07-23 | Isis Innovation | Suppression of transplant rejection |
EP1758936A2 (en) * | 2004-06-22 | 2007-03-07 | Tolerrx Inc. | Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
AU2009231325B2 (en) | 2008-03-13 | 2014-09-18 | Biotest Ag | Agent for treating disease |
BRPI0909180A2 (pt) | 2008-03-13 | 2016-08-09 | Biotest Ag | composição farmacêutica, e, método de tratamento de uma doença autoimune |
ES2610327T3 (es) | 2008-03-13 | 2017-04-27 | Biotest Ag | Régimen de dosificación de anticuerpos anti-CD4 para el tratamiento de enfermedades autoinmunitarias |
MX2010013265A (es) * | 2008-06-06 | 2011-02-24 | Baylor Res Inst | Anticuerpos anti-cd8 bloquean cebado de efectores citotoxicos y conducen a generacion de celulas t cd8+ reguladoras. |
AR077718A1 (es) * | 2008-07-15 | 2011-09-21 | Genentech Inc | Metodos para tratar enfermedades autoinmunes usando anticuerpos anti cd4. formulacion farmaceutica |
GB0920944D0 (en) | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
WO2024112867A1 (en) | 2022-11-23 | 2024-05-30 | University Of Georgia Research Foundation, Inc. | Compositions and methods of use thereof for increasing immune responses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
-
1989
- 1989-05-31 GB GB898912497A patent/GB8912497D0/en active Pending
-
1990
- 1990-05-30 ZA ZA904174A patent/ZA904174B/xx unknown
- 1990-05-31 WO PCT/GB1990/000840 patent/WO1990015152A1/en active IP Right Grant
- 1990-05-31 DK DK90908270.3T patent/DK0474691T3/da active
- 1990-05-31 ES ES90908270T patent/ES2096588T3/es not_active Expired - Lifetime
- 1990-05-31 KR KR1019910701737A patent/KR0183029B1/ko not_active IP Right Cessation
- 1990-05-31 IE IE194990A patent/IE80735B1/en not_active IP Right Cessation
- 1990-05-31 EP EP90908270A patent/EP0474691B1/en not_active Expired - Lifetime
- 1990-05-31 AU AU57258/90A patent/AU657255B2/en not_active Expired
- 1990-05-31 MY MYPI90000913A patent/MY135673A/en unknown
- 1990-05-31 CA CA002055615A patent/CA2055615C/en not_active Expired - Lifetime
- 1990-05-31 IL IL94566A patent/IL94566A0/xx unknown
- 1990-05-31 DE DE69029134T patent/DE69029134T2/de not_active Expired - Lifetime
- 1990-05-31 HU HU905134A patent/HUT61341A/hu unknown
- 1990-05-31 JP JP2508030A patent/JP2763197B2/ja not_active Expired - Lifetime
- 1990-05-31 DD DD90341218A patent/DD296843A5/de not_active IP Right Cessation
- 1990-05-31 PT PT94214A patent/PT94214B/pt not_active IP Right Cessation
- 1990-05-31 NZ NZ233889A patent/NZ233889A/en unknown
- 1990-05-31 AT AT90908270T patent/ATE145246T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY135673A (en) | 2008-06-30 |
PT94214B (pt) | 1997-03-31 |
EP0474691B1 (en) | 1996-11-13 |
CA2055615A1 (en) | 1990-12-13 |
DE69029134D1 (de) | 1996-12-19 |
HUT61341A (en) | 1992-12-28 |
EP0474691A1 (en) | 1992-03-18 |
CA2055615C (en) | 2001-07-17 |
PT94214A (pt) | 1991-02-08 |
AU657255B2 (en) | 1995-03-09 |
WO1990015152A1 (en) | 1990-12-13 |
IE80735B1 (en) | 1998-12-30 |
JPH04505919A (ja) | 1992-10-15 |
AU5725890A (en) | 1991-01-07 |
IL94566A0 (en) | 1991-03-10 |
JP2763197B2 (ja) | 1998-06-11 |
ES2096588T3 (es) | 1997-03-16 |
IE901949L (en) | 1990-11-30 |
GB8912497D0 (en) | 1989-07-19 |
DE69029134T2 (de) | 1997-03-06 |
ZA904174B (en) | 1992-02-26 |
NZ233889A (en) | 1997-06-24 |
ATE145246T1 (de) | 1996-11-15 |
DK0474691T3 (da) | 1996-12-02 |
KR0183029B1 (ko) | 1999-04-01 |
DD296843A5 (de) | 1991-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU905134D0 (en) | Molecular antibodies for the indication of tolerance | |
IL93840A0 (en) | Novel monoclonal antibody to novel antigen associated with human tumors | |
EP0285059A3 (en) | Monoclonal antibodies against glycolipid antigens and their use | |
IL73437A0 (en) | Method and test kit for detecting immune complexes in human serum | |
DE69221147T2 (de) | Nicht glycosylierter Anti-CD3-IgG-Antikörper | |
MY104946A (en) | Antigen antibody conjugate. | |
ES8609731A1 (es) | Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero | |
ES2013328A6 (es) | Un metodo para detectar anticuerpos contra antigenos hiv-1. | |
EP0359063A3 (en) | Antibody having high affinity to hapten as antigen and immunogen for obtaining the same | |
ZA887771B (en) | Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes | |
MY107079A (en) | Method of reducing immunoglobulin e responses | |
EP0335134A3 (en) | Mouse monoclonal antibody to human immunodeficiency virus gp41 protein | |
EP0153871A3 (en) | Antibody enhancement of immunogenicity of antigen | |
EP0460607A3 (en) | Novel monoclonal antibody to novel antigen associated with human tumors | |
GB2254326B (en) | Monoclonal antibodies produced by in vitro immunization of lymphocytes | |
ATE77243T1 (de) | E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom. | |
CA2054689A1 (en) | An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen | |
DE3273844D1 (en) | Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor | |
SE8705137D0 (sv) | Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method | |
EP0334076A3 (en) | Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same | |
EP0370768A3 (en) | Monoclonal antibody for the antigen specific to carcinoma of the thyroid | |
GB1155683A (en) | New Polyvalent Immunizing Agents and Methods for their Production | |
IT1254570B (it) | Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione. | |
BG51731A1 (en) | Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome | |
MX9707295A (es) | Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |